| dc.creator |
Karaoui, Lamis |
en_US |
| dc.creator |
Samah, Tawil |
en_US |
| dc.date.accessioned |
2017-12-19T12:49:41Z |
|
| dc.date.available |
2017-12-19T12:49:41Z |
|
| dc.date.datecopyrighted |
2011 |
en_US |
| dc.identifier.issn |
1530-0293 |
en_US |
| dc.identifier.uri |
http://hdl.handle.net/10725/6842 |
|
| dc.language.iso |
en |
en_US |
| dc.title |
801 |
en_US |
| dc.type |
Article |
en_US |
| dc.description.version |
Published |
en_US |
| dc.title.subtitle |
Efficacy and safety of enoxaparin 20 mg subcutaneously in patients with chronic kidney disease stages 4 and 5 for deep vein thrombosis prophylaxis |
en_US |
| dc.creator.school |
SOP |
en_US |
| dc.creator.identifier |
200101817 |
en_US |
| dc.creator.department |
Pharmacy Practice Department |
en_US |
| dc.description.embargo |
N/A |
en_US |
| dc.relation.ispartof |
Critical Care Medicin |
en_US |
| dc.description.volume |
39 |
en_US |
| dc.description.issue |
12 |
en_US |
| dc.article.pages |
225 |
en_US |
| dc.identifier.doi |
http://dx.doi.org/10.1097/01.ccm.0000408627.24229.88 |
en_US |
| dc.identifier.ctation |
Karaoui, L., & Tawil, S. (2011). 801: Efficacy And Safety Of Enoxaparin 20 Mg Subcutaneously In Patients With Chronic Kidney Disease Stages 4 And 5 For Deep Vein Thrombosis Prophylaxis. Critical Care Medicine, 39(12), 225. |
en_US |
| dc.creator.email |
lamis.karaoui@lau.edu.lb |
en_US |
| dc.description.tou |
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php |
en_US |
| dc.identifier.url |
http://journals.lww.com/ccmjournal/Citation/2011/12001/801__EFFICACY_AND_SAFETY_OF_ENOXAPARIN_20_MG.757.aspx |
en_US |
| dc.creator.ispartof |
Lebanese American University |
en_US |